Drugs / FE 999324
last change Jan 2026 re-read 3 minutes ago

FE 999324

Developed for
ulcerative colitis
Investigated by
Ferring Pharmaceuticals

Trials 1

20252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT06260267 Mar 2024 → Jan 2026 ulcerative colitis Ferring Pharmaceuticals Withdrawn No outcome recorded Stop: Business

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FE 999324 “FE 999324” NCT06260267 ↗